ATE366258T1 - Gp120-mutanten und deren biologische verwendungen - Google Patents

Gp120-mutanten und deren biologische verwendungen

Info

Publication number
ATE366258T1
ATE366258T1 AT99973070T AT99973070T ATE366258T1 AT E366258 T1 ATE366258 T1 AT E366258T1 AT 99973070 T AT99973070 T AT 99973070T AT 99973070 T AT99973070 T AT 99973070T AT E366258 T1 ATE366258 T1 AT E366258T1
Authority
AT
Austria
Prior art keywords
mutants
biological uses
hxbc2
hiv
mutant
Prior art date
Application number
AT99973070T
Other languages
English (en)
Inventor
Francisco Veas
Martine Cerutti
Original Assignee
Inst Rech Developpement Ird
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Rech Developpement Ird filed Critical Inst Rech Developpement Ird
Application granted granted Critical
Publication of ATE366258T1 publication Critical patent/ATE366258T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT99973070T 1998-11-27 1999-11-29 Gp120-mutanten und deren biologische verwendungen ATE366258T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9814997A FR2786488B1 (fr) 1998-11-27 1998-11-27 Mutants de la gp120 et leurs applications biologiques

Publications (1)

Publication Number Publication Date
ATE366258T1 true ATE366258T1 (de) 2007-07-15

Family

ID=9533301

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99973070T ATE366258T1 (de) 1998-11-27 1999-11-29 Gp120-mutanten und deren biologische verwendungen

Country Status (8)

Country Link
US (1) US7078038B1 (de)
EP (1) EP1159427B1 (de)
JP (1) JP4489299B2 (de)
AT (1) ATE366258T1 (de)
CA (1) CA2352603C (de)
DE (1) DE69936464T2 (de)
FR (1) FR2786488B1 (de)
WO (1) WO2000032786A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013279456A1 (en) * 2012-06-18 2014-12-18 Glaxosmithkline Biologicals Sa Stabilized gp120

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE68918867T2 (de) * 1988-09-13 1995-02-16 Chiron Corp Mutanten des hiv-1 Hüllproteins mit fehlenden hypervariabelen domänen.
US20030104577A1 (en) * 1997-02-07 2003-06-05 Uc Regents HIV capsid assembly-associated compositions and method

Also Published As

Publication number Publication date
JP2002542146A (ja) 2002-12-10
FR2786488A1 (fr) 2000-06-02
EP1159427A1 (de) 2001-12-05
DE69936464T2 (de) 2008-03-13
US7078038B1 (en) 2006-07-18
WO2000032786A1 (fr) 2000-06-08
EP1159427B1 (de) 2007-07-04
JP4489299B2 (ja) 2010-06-23
FR2786488B1 (fr) 2003-04-25
DE69936464D1 (de) 2007-08-16
CA2352603C (fr) 2012-03-20
CA2352603A1 (fr) 2000-06-08

Similar Documents

Publication Publication Date Title
ES2078255T3 (es) Regiones inmunogenas en la proteina e-7 del papilomavirus humano tipo 16.
ATE259828T1 (de) Prosaposin und cytokinabhängige peptide als therapeutisch wirksame mittel
SI0887427T1 (sl) Pomnozevanje in detekcija HIV-1 in/ali HIV-2
ATE383424T1 (de) Polypeptide, deren herstellung und verwendung
ATE264914T1 (de) Antivirale proteine, dafür kodierende dna, und deren verwendung
ES2192620T3 (es) Polipeptido receptor de il-13.
DE60037450D1 (de) Funf-helix protein
ATE133181T1 (de) Dehydrodidemnin b
ATE519500T1 (de) Mutanten von hüllglykoproteinen des human immunodeficiency virus und deren verwendung
ATE331037T1 (de) Isoliertes frpb nukleinsäuremolekül und entsprechende impfstoff
MX9708426A (es) Polipeptido hk2 de variante estable.
NZ305188A (en) DNA encoding Human Papilloma Virus (hPV)type 18
DE69936464D1 (de) Gp120-mutanten und deren biologische verwendungen
PT975783E (pt) "vectores retrovirais, processo para a sua producao e sua utilizacao para a transferencia de genes a celulas cd4-positivas"
DE59105636D1 (de) Expression von HIV1- und 2- Polypeptiden und deren Verwendung.
WO2000027880A3 (en) Rantes-derived peptides with anti-hiv activity
ATE308616T1 (de) Rantes mutanten und deren therapeutische verwendungen
ATE143974T1 (de) Peptide des hiv-gag proteins, ihre herstellung und verwendung
AP9901615A0 (en) Multiple branch peptide constructions.
FI960839A (fi) Uusia tripeptidejä, jotka ovat käyttökelpoisia immuuni- ja CNS-terapiassa
ES2066897T3 (es) 5,11-dihidro-6h-pirido(2,3-b)(1,4)benzodiazepin-6-onas y -tionas y su uso en la prevencion o el tratamiento del sida.
DE69733026D1 (de) Cyclin e spezifische konstrukte und komplexe
ATE75486T1 (de) Anorexigenische und hypotensive peptide.
AU7614798A (en) High level expression, purification and refolding of the Neisseria meningitidis outer membrane group B porin proteins
ECSP982804A (es) Beta- lipotropina y usos de la misma

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties